Sandu Pharmaceuticals Ltd — Important, 07-07-2026: Company Update

Sandu Pharmaceuticals has announced that its Registrar and Share Transfer Agent has confirmed the proper processing of all share dematerialization requests for the quarter ended June 30, 2026. This indicates that all physical shares submitted for conversion into electronic form were correctly processed, listed on exchanges, and the company's records were updated accordingly. This routine compliance update assures investors of accurate and efficient management of their shareholdings, maintaining the integrity of the company's shareholder registry.